These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 19113922

  • 1. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.
    Binkley N, Harke J, Krueger D, Engelke J, Vallarta-Ast N, Gemar D, Checovich M, Chappell R, Suttie J.
    J Bone Miner Res; 2009 Jun; 24(6):983-91. PubMed ID: 19113922
    [Abstract] [Full Text] [Related]

  • 2. Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats.
    Binkley N, Krueger D, Engelke J, Crenshaw T, Suttie J.
    Bone; 2002 Jun; 30(6):897-900. PubMed ID: 12052460
    [Abstract] [Full Text] [Related]

  • 3. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
    Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R.
    PLoS Med; 2008 Oct 14; 5(10):e196. PubMed ID: 18922041
    [Abstract] [Full Text] [Related]

  • 4. Effect of phylloquinone (vitamin K1) supplementation for 12 months on the indices of vitamin K status and bone health in adult patients with Crohn's disease.
    O'Connor EM, Grealy G, McCarthy J, Desmond A, Craig O, Shanahan F, Cashman KD.
    Br J Nutr; 2014 Oct 14; 112(7):1163-74. PubMed ID: 25181575
    [Abstract] [Full Text] [Related]

  • 5. Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone (vitamin K(1)) or menaquinone-7 (vitamin K (2)): the Postmenopausal Health Study II.
    Kanellakis S, Moschonis G, Tenta R, Schaafsma A, van den Heuvel EG, Papaioannou N, Lyritis G, Manios Y.
    Calcif Tissue Int; 2012 Apr 14; 90(4):251-62. PubMed ID: 22392526
    [Abstract] [Full Text] [Related]

  • 6. Effects of vitamin K in postmenopausal women: mini review.
    Guralp O, Erel CT.
    Maturitas; 2014 Mar 14; 77(3):294-9. PubMed ID: 24342502
    [Abstract] [Full Text] [Related]

  • 7. Vitamin K, bone turnover, and bone mass in girls.
    Kalkwarf HJ, Khoury JC, Bean J, Elliot JG.
    Am J Clin Nutr; 2004 Oct 14; 80(4):1075-80. PubMed ID: 15447922
    [Abstract] [Full Text] [Related]

  • 8. Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.
    Bügel S, Sørensen AD, Hels O, Kristensen M, Vermeer C, Jakobsen J, Flynn A, Mølgaard C, Cashman KD.
    Br J Nutr; 2007 Feb 14; 97(2):373-80. PubMed ID: 17298708
    [Abstract] [Full Text] [Related]

  • 9. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
    Kruger MC, Booth CL, Coad J, Schollum LM, Kuhn-Sherlock B, Shearer MJ.
    Nutrition; 2006 Feb 14; 22(11-12):1120-8. PubMed ID: 17030114
    [Abstract] [Full Text] [Related]

  • 10. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.
    Bolton-Smith C, McMurdo ME, Paterson CR, Mole PA, Harvey JM, Fenton ST, Prynne CJ, Mishra GD, Shearer MJ.
    J Bone Miner Res; 2007 Apr 14; 22(4):509-19. PubMed ID: 17243866
    [Abstract] [Full Text] [Related]

  • 11. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
    Inoue T, Sugiyama T, Matsubara T, Kawai S, Furukawa S.
    Endocr J; 2001 Feb 14; 48(1):11-8. PubMed ID: 11403096
    [Abstract] [Full Text] [Related]

  • 12. Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women.
    Volpe SL, Leung MM, Giordano H.
    Nutr Res; 2008 Sep 14; 28(9):577-82. PubMed ID: 19083462
    [Abstract] [Full Text] [Related]

  • 13. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ, MK-677/Alendronate Study Group.
    J Clin Endocrinol Metab; 2001 Mar 14; 86(3):1116-25. PubMed ID: 11238495
    [Abstract] [Full Text] [Related]

  • 14. Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults.
    Binkley NC, Krueger DC, Engelke JA, Foley AL, Suttie JW.
    Am J Clin Nutr; 2000 Dec 14; 72(6):1523-8. PubMed ID: 11101481
    [Abstract] [Full Text] [Related]

  • 15. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
    Rønn SH, Harsløf T, Oei L, Pedersen SB, Langdahl BL.
    Osteoporos Int; 2021 Jan 14; 32(1):185-191. PubMed ID: 33030563
    [Abstract] [Full Text] [Related]

  • 16. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E.
    Osteoporos Int; 2013 Sep 14; 24(9):2499-507. PubMed ID: 23525894
    [Abstract] [Full Text] [Related]

  • 17. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.
    Shiraki M, Itabashi A.
    J Bone Miner Metab; 2009 Sep 14; 27(3):333-40. PubMed ID: 19172219
    [Abstract] [Full Text] [Related]

  • 18. Vitamin K₂ therapy for postmenopausal osteoporosis.
    Iwamoto J.
    Nutrients; 2014 May 16; 6(5):1971-80. PubMed ID: 24841104
    [Abstract] [Full Text] [Related]

  • 19. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.
    Osteoporos Int; 2006 May 16; 17(5):716-23. PubMed ID: 16463007
    [Abstract] [Full Text] [Related]

  • 20. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
    Miller PD, Chines AA, Christiansen C, Hoeck HC, Kendler DL, Lewiecki EM, Woodson G, Levine AB, Constantine G, Delmas PD.
    J Bone Miner Res; 2008 Apr 16; 23(4):525-35. PubMed ID: 18072873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.